GOOD JENNIFER L 4
4 · Trevi Therapeutics, Inc. · Filed Mar 25, 2025
Insider Transaction Report
Form 4
GOOD JENNIFER L
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Common Stock
2025-03-21$1.43/sh+5,263$7,526→ 218,576 total - Sale
Common Stock
2025-03-21$6.58/sh−5,263$34,625→ 213,313 total - Exercise/Conversion
Stock Option (right to buy)
2025-03-21−5,263→ 0 totalExercise: $1.43Exp: 2025-05-14→ Common Stock (5,263 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.55 to $6.60 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F2]This option was granted on May 15, 2015. The 5,263 shares of common stock underlying the option vested as to 25% of the shares on May 15, 2016 and vested as to the remaining 75% of the shares in equal monthly installments thereafter through May 15, 2019.